MetLife Investment Management’s Hippo Holdings HIPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$273K Sell
10,463
-189
-2% -$5.38K ﹤0.01% 2062
2025
Q4
$320K Sell
10,652
-729
-6% -$24.4K ﹤0.01% 2027
2025
Q3
$412K Sell
11,381
-1,771
-13% -$55.1K ﹤0.01% 1899
2025
Q2
$367K Hold
13,152
﹤0.01% 1831
2025
Q1
$336K Sell
13,152
-242
-2% -$6.72K ﹤0.01% 1914
2024
Q4
$359K Buy
13,394
+1,573
+13% +$38.7K ﹤0.01% 1978
2024
Q3
$200K Hold
11,821
﹤0.01% 2288
2024
Q2
$203K Buy
11,821
+5,846
+98% +$111K ﹤0.01% 2235
2024
Q1
$109K Buy
+5,975
New +$73.6K ﹤0.01% 2491
2023
Q3
Sell
-6,867
Closed -$114K 2924
2023
Q2
$114K Sell
6,867
-2,641
-28% -$45.8K ﹤0.01% 2601
2023
Q1
$154K Hold
9,508
﹤0.01% 2369
2022
Q4
$129K Hold
9,508
﹤0.01% 2482
2022
Q3
$176K Buy
9,508
+3,390
+55% +$75K ﹤0.01% 2380
2022
Q2
$134K Buy
+6,118
New +$226K ﹤0.01% 2561

Other funds holding HIPO

MetLife Investment Management's HIPO Position: Q1 2026 in Review

MetLife Investment Management reduced its Hippo Holdings (HIPO) stake by 1.8% in Q1 2026, selling an estimated $5.38K and leaving 10,463 shares worth $273K. The position accounts for ﹤0.01% of the portfolio, ranked #2062.

MetLife Investment Management first reported a position in HIPO in Q2 2022 and has held it in 14 quarters since. The position peaked at $412K in Q3 2025. 128 funds tracked by Wall St. Rank hold HIPO as of Q1 2026.

  • MetLife Investment Management held 10,463 shares of Hippo Holdings worth $273K as of Q1 2026.
  • MetLife Investment Management sold 189 Hippo Holdings shares in Q1 2026, an estimated $5.38K.
  • Hippo Holdings made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2062 holding.
  • MetLife Investment Management first reported a position in Hippo Holdings in Q2 2022 and has held it in 14 quarters since.
  • MetLife Investment Management's Hippo Holdings position peaked at $412K in Q3 2025.
  • 128 funds tracked by Wall St. Rank held Hippo Holdings as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.